64
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Fludarabine-Induced Apoptosis in CD19+?/CD5+ B-CLL Cells is a Direct and Nurse-Like-Cell Independent Effect

, , , , , & show all
Pages 2307-2314 | Published online: 01 Jul 2009

References

  • Reed, J.C., Kitada, S., Kim, Y. and Byrd, J. (2002) "Modulating apoptosis pathways in low-grade B-cell malignancies using biologi-cal response modifiers", Seminars in Oncology, 29, 10–24.
  • Chiorazzi, N. and Ferrarini, M. (2003) "B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor", Annual Review of Immunology, 21, 841 —894.
  • Kipps, T.J. (2000) "Chronic lymphocytic leukemia", Current Opinion in Hematology, 7, 223–234.
  • Collins, R.J., Verschuer, L.A., Harmon, B.V., Prentice, R.L., Pope, J.H. and Kerr, J.F. (1989) "Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro", British Journal of Haematology, 71, 343–350.
  • Bellosillo, B., Villamor, N., Lopez-Guillermo, A., Marce, S., Bosch, F., Campo, E., et al. (2002) "Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia", Blood, 100, 1810 — 1816.
  • Jurlander, J. (1998) "The cellular biology of B-cell chronic lymphocytic leukemia", Critical Reviews in Oncology Hematology, 27, 29 — 52.
  • Moreno, A., Villar, ML., Camara, C., Luque, R., Cespon, C., Gonzalez-Porque, P., et al. (2001) "Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells", Blood, 97, 242— 249.
  • Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C. and Stryck-mans, P. (1998) "Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells", Blood, 91, 2387 — 2396.
  • Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L. and Hoffbrand, A.V. (1996) "Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro", British Journal of Haematology, 92, 97 — 103.
  • Burger, J.A., Tsukada, N., Burger, M., Zvaifler, N.J., Dell'Aquila, M. and Kipps, T.J. (2000) "Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1", Blood, 96, 2655–2663.
  • Burger, J.A. and Kipps, T.J. (2002) "Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells", Leukemia and Lymphoma, 43, 461–466.
  • Tsukada, N., Burger, J.A., Zvaifler, N.J. and Kipps, Ti. (2002) "Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia", Blood, 99, 1030— 1037.
  • Tallman, M.S. and Hakimian, D. (1995) "Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders", Blood, 86, 2463–2474.
  • Robertson, L.E., Chubb, S., Meyn, R.E., Story, M., Ford, R., Hittelman, W.N., et al. (1993) "Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosy1-2-fluoroadenine", Blood, 81, 143–150.
  • Plunkett, W., Huang, P. and Gandhi, V. (1990) "Metabolism and action of fludarabine phosphate", Seminars in Oncology, 17, 3— 17.
  • Li, L., Liu, X., Glassman, A.B., Keating, Mi., Stros, M., Plunkett, W. and Yang, L.Y. (1997) "Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro", Cancer Research, 57, 1487 — 1494.
  • Fabianowska-Majewska, K., Ruckemann, K., Duley, J.A. and Simmonds, H.A. (1998) "Effect of Cladribine, fludarabine, and 5-aza-deoxycytidine on S-adenosylmethionine (SAM) and nucleotides pools in stimulated human lymphocytes", Advances in Experimental Medicine Biology, 431, 531 — 535.
  • Frank, D.A., Mahajan, S. and Ritz, J. (1999) "Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signal-ing", Nature Medicine, 5, 444–447.
  • Huang, P., Sandoval, A., Van Den Neste, E., Keating, M.J. and Plunkett, W. (2000) "Inhibition of RNA transcription: a biochem-ical mechanism of action against chronic lymphocytic leukemia cells by fludarabine", Leukemia, 14, 1405 — 1413.
  • Thomas, A., El Rouby, S., Reed, J.C., Krajewski, S., Silber, R., Potmesil, M. and Newcomb, E.W. (1996) "Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bc1-2/bax proteins in drug resistance," Oncogene, 12, 1055 — 1062.
  • Koopman, G., Reutelingsperger, C.P., Kuijten, G.A., Keehnen, R.M., Pals, S.T. and van Oers, M.H. (1994) "Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis", Blood, 84, 1415–1420.
  • Kitada, S., Andersen, J., Akar, S., Zapata, J.M., Takayama, S., Krajewski, S., et al. (1998) "Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses", Blood, 91, 3379 — 3389.
  • Caligaris-Cappio, F. and Hamblin, T.J. (1999) "B-cell chronic lymphocytic leukemia: a bird of a different feather", Journal of Clinical Oncology, 17, 399–408.
  • McConkey, D.J., Chandra, J., Wright, S., Plunkett, W., McDonnell, Ti., Reed, J.C., et al. (1996) "Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX", Journal of Immunology, 156, 2624–2630.
  • Bergmann, L. (1997) "Present status of purine analogs in the therapy of chronic lymphocytic leukemias", Leukemia, 11\(Suppl 2), S29 — S34.
  • Savage, D.G., Cohen, N.S., Hesdorffer, CS., Heitjan, D., Oster, M.W., Garrett, Ti., et al. (2003) "Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia", Leukemia and Lymphoma, 44, 477–481.
  • Ghia, P., Granziero, L., Chilosi, M. and Caligaris-Cappio, F. (2002) "Chronic B cell malignancies and bone marrow microenviron-ment", Seminars in Cancer Biology, 12, 149 — 155.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.